EP Global Communications Inc fka EPGL

[Valiant]

EPGLMed history:

2012 - EPGL restructured under Michael Hayes and PWC to start a medical device company
2012 - EPGL hired David Markus who specializes in BioMems - They put together plans for 16 new medical devices that they would develop and invent. 2 of which were relating to vision care and smart contact lenses.
2013 - Signed a development agreement with Coopervision.
2015 - Coopervision tried to take the tech without having to pay what the original development agreement had stated. EPGL throated to sue. EPGL signed a development agreement with AT&T to develop multiple products for concussion with NFLspeaks, and other technologies that haven't been disclosed.
2016 - EPGL got out of the agreement with Coopervision & obtained rights to all their tech 100%. Signed a first rights of purchase agreement with Johnson & Johnson. EPGL obtained it's first patent award and has many more coming soon.

Michael Hayes isn't a liar. He is a CEO trying to build a business from scratch. He made a conscious decision to set the MPDD aside and focus on Bio Mems when David Markus joined the team, because the opportunity was much greater and the technology was ground breaking. He has moved EPGL from .001 to our current levels and kept us informed along the way. Been a fun ride and he has stated that EPGLs buyout target is .88 to 1.0 a share.